000154502 001__ 154502
000154502 005__ 20240303004155.0
000154502 0247_ $$2doi$$a10.1186/s13014-020-01529-z
000154502 0247_ $$2pmid$$apmid:32293497
000154502 0247_ $$2altmetric$$aaltmetric:147026818
000154502 037__ $$aDKFZ-2020-00824
000154502 041__ $$aeng
000154502 082__ $$a610
000154502 1001_ $$0P:(DE-HGF)0$$aSprave, Tanja$$b0
000154502 245__ $$aRadiotherapeutic management of cervical lymph node metastases from an unknown primary site - experiences from a large cohort treated with modern radiation techniques.
000154502 260__ $$aLondon$$bBioMed Central$$c2020
000154502 3367_ $$2DRIVER$$aarticle
000154502 3367_ $$2DataCite$$aOutput Types/Journal article
000154502 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1675087220_23510
000154502 3367_ $$2BibTeX$$aARTICLE
000154502 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154502 3367_ $$00$$2EndNote$$aJournal Article
000154502 520__ $$aTo analyze management and outcomes following (chemo)radiation therapy in patients with cervical lymph node metastases from an unknown primary site (CCUP) in a large single-center cohort.Between 2008 and 2019, 58 patients with CCUP were treated with (chemo)radiation therapy at the University of Freiburg Medical Center and were included in this analysis. Overall survival (OS), locoregional progression-free survival (PFS) and distant metastasis-free survival (DMFS) were calculated using the Kaplan-Meier method. The use of diagnostic procedures and their impact on oncological outcomes was analyzed by Cox regression, and treatment-related toxicities were quantified.Median follow-up was 29.9 months (range 4.6-121.9). Twenty-one patients (36.2%) received definitive RT, 35 (60.3%) underwent adjuvant RT, and 2 (3.4%) were treated for oligometastatic disease. Concurrent chemotherapy was prescribed in 40 patients (69.0%). 89.6% of patients completed the prescribed RT, and 65.0% completed the prescribed simultaneous chemotherapy. Locoregional recurrence was observed in 7 patients (12.1%) and distant metastases in 13 cases (22.4%). OS was 81,1, 64.9% and 56,6% after 1, 3 and 5 years, respectively. Univariate analysis of age, gender, extracapsular spread, tumor grading, neck dissection, diagnostic utilization of 18F-fluorodeoxyglucose positron-emission tomography and concomitant chemotherapy showed no effect on OS (p > 0.05 for all), while smoking was significantly associated with decreased survival (p < 0.05). There was a trend towards impaired OS for patients with advanced nodal status (pN3) (p = 0.07). Three patients (5.2%) experienced grade 3 radiation dermatitis, and 12 (22.4%) developed grade 3 and 1 (1.7%) grade 4 mucositis.RT of the panpharynx and cervical lymph nodes with concurrent chemotherapy in case of risk factors demonstrated good locoregional control, but the metachronous occurrence of distant metastases limited survival and must be further addressed.
000154502 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000154502 588__ $$aDataset connected to CrossRef, PubMed,
000154502 7001_ $$0P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aRühle, Alexander$$b1
000154502 7001_ $$aHees, Katharina$$b2
000154502 7001_ $$0P:(DE-HGF)0$$aKalckreuth, Tobias$$b3
000154502 7001_ $$aVerma, Vivek$$b4
000154502 7001_ $$aStoian, Raluca$$b5
000154502 7001_ $$0P:(DE-HGF)0$$aZamboglou, Constantinos$$b6
000154502 7001_ $$aPfeiffer, Jens$$b7
000154502 7001_ $$aLaszig, Roland$$b8
000154502 7001_ $$aKnopf, Andreas$$b9
000154502 7001_ $$0P:(DE-HGF)0$$aGrosu, Anca-Ligia$$b10
000154502 7001_ $$0P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aNicolay, Nils$$b11$$eLast author
000154502 773__ $$0PERI:(DE-600)2224965-5$$a10.1186/s13014-020-01529-z$$gVol. 15, no. 1, p. 80$$n1$$p80$$tRadiation oncology$$v15$$x1748-717X$$y2020
000154502 909CO $$ooai:inrepo02.dkfz.de:154502$$pVDB
000154502 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000154502 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)80e100a16534f5fc67f7436ee67a47f9$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000154502 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000154502 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000154502 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000154502 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d52e7ff1ccaac7dbf0232fdcb0168bd$$aDeutsches Krebsforschungszentrum$$b11$$kDKFZ
000154502 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000154502 9141_ $$y2020
000154502 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154502 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154502 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000154502 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000154502 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000154502 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000154502 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000154502 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000154502 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000154502 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000154502 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154502 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154502 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154502 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000154502 9201_ $$0I:(DE-He78)FR01-20160331$$kFR01$$lDKTK FR zentral$$x0
000154502 9201_ $$0I:(DE-He78)E055-20160331$$kE055$$lE055 KKE Molekulare Radioonkologie$$x1
000154502 980__ $$ajournal
000154502 980__ $$aVDB
000154502 980__ $$aI:(DE-He78)FR01-20160331
000154502 980__ $$aI:(DE-He78)E055-20160331
000154502 980__ $$aUNRESTRICTED